| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 06/07/2006 | EP0797675B1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 06/07/2006 | EP0783583B1 Cytoplasmic tyrosine kinase |
| 06/07/2006 | EP0777726B1 Microbial transglutaminases, their production and use |
| 06/07/2006 | EP0733115B1 Novel cellulase enzymes and systems for their expression |
| 06/07/2006 | CN1784496A Multiple gene transcription activity determining system |
| 06/07/2006 | CN1784495A Methods and means for increasing the tolerance of plants to stress conditions |
| 06/07/2006 | CN1784493A Modified beta-lactamases and uses thereof |
| 06/07/2006 | CN1784490A Variant subtilisin enzymes (subtilases) |
| 06/07/2006 | CN1784410A Protein kinase inhibitors |
| 06/07/2006 | CN1782086A Adeno-associated virus mediating trigenic cell expression system |
| 06/07/2006 | CN1782083A Novel thrombase-like gene and its use |
| 06/07/2006 | CN1782082A Purified polyporus laccases and nucleic acids encoding same |
| 06/07/2006 | CN1782081A Purified polyporus laccases and nucleic acids encoding same |
| 06/07/2006 | CN1782071A Recombinant mva virus and the use thereof |
| 06/07/2006 | CN1782070A Plasmin producing strain and method for producing plasmin |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1258593C Putrescine-N-methyl transferase promoter |
| 06/07/2006 | CN1258590C Oriented culturing method for increasing resistance of nitrile hydratase product |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258380C Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/06/2006 | US7057091 Comprises nucleotide sequences coding mitochondrial enzymatic polypeptide for improving fatty acid biosynthesis, glycerolipid storage, seed size and weight, flowering and generation time of plants; antisense therapy |
| 06/06/2006 | US7057088 Genetic engineered transgenic plant; controlling,germination |
| 06/06/2006 | US7057030 Useful for conversion of aldoxime substrates to nitrilases and other downstream intermediates; gene has been cloned into recombinant host and expressed |
| 06/06/2006 | US7057020 Isolated RuvB polypeptides |
| 06/06/2006 | US7056900 Disaccharide derivatives for treating hyperglycaemia |
| 06/06/2006 | US7056899 Disaccharide derivatives for treating hyperglycaemia |
| 06/06/2006 | US7056740 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms |
| 06/06/2006 | US7056731 Sulfotransferase SULT2A1 sequence variants |
| 06/06/2006 | US7056722 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 06/06/2006 | US7056721 EGVI endoglucanase and nucleic acids encoding the same |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056719 Polypeptide-phosphatidic acid phosphatase 29.81 and the polynucleotide encoding said polypeptide |
| 06/06/2006 | US7056718 Genetic engineering; hybrid polynucleotides; |
| 06/06/2006 | US7056717 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis |
| 06/06/2006 | US7056716 High fidelity reverse transcriptases and uses thereof |
| 06/06/2006 | US7056715 GST sequences from soybean and their use in the production of herbicide resistant plants |
| 06/06/2006 | US7056714 Nucleotide sequences comprising gene coding protein associated with complex, multicomponent enzyme systems for use in biogeneration of synthetic, aromatic, aliphatic and alicyclic aldehydes and alcohols |
| 06/06/2006 | US7056713 Reduced immunology; bioavailability; genetic engineered protein |
| 06/06/2006 | US7056712 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 06/06/2006 | US7056711 Attenuation of fibroblast proliferation |
| 06/06/2006 | US7056709 Isolation and expression of a gene for a nitrilase from Acidovorax faclilis 72W |
| 06/06/2006 | US7056703 Nucleotide sequences coding enzymetic polypeptide for use as tool in amplification of nucleotide sequences |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056699 Vector capable of transduction non-dividing or slowly diviving cell; gene expression in protein; genetic engineering |
| 06/06/2006 | US7056697 FabK variant |
| 06/06/2006 | US7056692 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 06/06/2006 | US7056691 Assays for identifying α-galactosidases |
| 06/06/2006 | US7056554 Production of polyelectrolyte capsules by surface precipitation |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056513 Peptides for use in the treatment of cancer and aging |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056504 Rationally designed heparinases derived from heparinase I and II |
| 06/06/2006 | CA2386587C Genes and proteins for the biosynthesis of anthramycin |
| 06/06/2006 | CA2367105C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2367024C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2301044C Antimicrobial peptide and dna construct and expression system thereof |
| 06/01/2006 | WO2006058092A2 Monosaccharide production system |
| 06/01/2006 | WO2006057450A1 L-amino acid-producing bacterium and a method for producing l-amino acid |
| 06/01/2006 | WO2006057396A1 Method of reconstituting proteasome |
| 06/01/2006 | WO2006056821A1 Heterologus expression of trypanothione reductase from leishmania donovani in a prokaryotic system |
| 06/01/2006 | WO2006056663A1 Method of screening compounds for the treatment of diabetes |
| 06/01/2006 | WO2006056469A1 Enzyme formulations |
| 06/01/2006 | WO2006056259A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | WO2006056007A1 Inhibitors of biotin protein ligase |
| 06/01/2006 | WO2006029538A8 Sialyltransferases comprising conserved sequence motifs |
| 06/01/2006 | WO2006029485A3 Overexpressed and purified aspergillus ficuum oxidase and nucleic acid encoding the same |
| 06/01/2006 | WO2006029398A8 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
| 06/01/2006 | WO2006029296A3 Inositol polyphosphate 2-kinase genes and uses thereof |
| 06/01/2006 | WO2005121331A9 Truncated galnact2 polypeptides and nucleic acids |
| 06/01/2006 | WO2005118796A3 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
| 06/01/2006 | WO2005115458A9 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
| 06/01/2006 | WO2005111216A3 Methods for modifying plant characteristics |
| 06/01/2006 | WO2005109995A3 Thermostable gluconate dehydratase and use thereof |
| 06/01/2006 | WO2005103243A3 Carboxypeptidases b from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | WO2004085617B1 TIMP3 as VEGF inhibitor |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060117413 generating transgenic plantS comprising introducing into a somatic embryo, a polynucleotide encoding dihydrodipicolinate synthase (DHPS) polypeptide, effective to render the embryo resistant to S-2-aminoethylcysteine; herbicide resistance |
| 06/01/2006 | US20060117409 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes |
| 06/01/2006 | US20060117407 Method of producing transgenic maize using direct transformation of commercially important genotypes |
| 06/01/2006 | US20060117401 Method for producing aminoacids |
| 06/01/2006 | US20060117395 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 06/01/2006 | US20060117394 Chimeric cells coding heterologous immunoglobulin for treatment, prevention and diagnosis of infections and cell proliferative disorders |
| 06/01/2006 | US20060116826 Crystals of cytochrome P450 2C9, structures thereof and their use |
| 06/01/2006 | US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor |
| 06/01/2006 | US20060116348 Using the hyaluronate synthase from Pasteurella multocida; coatings for biomaterials wherein the coatings provide protective properties to the biomaterial and/or act as a bioadhesive; coatings could be applied to electrical devices, sensors, catheters |
| 06/01/2006 | US20060115886 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma, aspergillus |
| 06/01/2006 | US20060115883 Regioselective hydrolysis of (E)-2-methyl-2-butenonitrile to (E)-2-methyl-2-butenoic acid (2M2BA) using enzyme catalysts having either a nitrilase activity or both of nitrile hydratase and amidase activities |
| 06/01/2006 | US20060115881 High eicosapentaenoic acid producing strains of Yarrowia lipolytica |
| 06/01/2006 | US20060115878 Method for producing L-amino acid |
| 06/01/2006 | US20060115877 Hyaluronate synthase gene and uses thereof |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof |
| 06/01/2006 | US20060115856 2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |